Gritstone Oncology to Present at Cowen and Company 38th Annual Health Care Conference

EMERYVILLE, Calif.--()--Gritstone Oncology, a next-generation personalized cancer immunotherapy company, today announced that Andrew Allen, M.D., PhD., President and Chief Executive Officer, will present at Cowen and Company’s 38th Annual Health Care Conference.

The presentation will take place on Monday, March 12, 2018 at 8:30 a.m. Eastern Time at the Boston Marriott Copley Place in Boston, MA.

About Gritstone Oncology

Gritstone Oncology is a privately-held, next-generation personalized cancer immunotherapy company. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors and deep financial backing to tackle fundamental challenges at the intersection of cancer genomics, immunology, and immunotherapy design. The Company’s initial goal is to leverage artificial intelligence to identify and deploy therapeutic neoantigens from individual patients’ tumors to develop novel treatments for lung, gastric, and colorectal cancer. In addition to neoantigen therapy development, Gritstone is leveraging its unique antigen discovery platform, EDGE™ (Epitope Discovery of cancer GEnomes), to define targets for shared antigen immunotherapies, which would provide an opportunity to treat even more patients. Gritstone Oncology is headquartered in the San Francisco Bay Area with key functions located in Cambridge, MA and Pleasanton, CA. The company launched in October 2015 and has received funding from leading blue-chip biotechnology investors, including Versant Ventures, The Column Group, Clarus Funds, Frazier Healthcare Partners, RedMile, Casdin Capital, Lilly Asia Ventures, Trinitas Capital, GV, Alexandria Venture Investments, and Bay City Capital. More information can be found at or @gritstoneonc.


Dan Budwick, 973-271-6085

Recent Stories

RSS feed for Gritstone Oncology

Release Summary

Gritstone Oncology President & CEO Andrew Allen, M.D., Ph.D. will present at the Cowen & Co. Health Care Conference in Boston next Monday.

Gritstone Oncology